Active: new fund Oct 2026 Verified 4 Nov 2026
IVP: Venture capital for the Exceptional
Menlo Park, CA venture firm backing fast-growing technology companies, citing around 400 portfolio companies over several decades.
- Type
- VC firm
- Location
- Menlo Park, California, United States
- Stages
- Series B, Growth
- Backs
- B2B software, Medtech and digital health
- Sectors
- AI, Healthtech and life sciences, Devtools
- Fund size / AUM
- $60M Ivp Xvii-g (Form D offering, 2026)
- Latest fund or filing
- 22 Oct 2026
- Portfolio mix
- B2B software 52%; Medtech and digital health 15%; Consumer apps 11%; Biotech and pharma 7%; Hardware 7%; Deep tech 4%; Fintech 4% (n=27)
- UK office
- London
- Website
- www.ivp.com
Fund filings (SEC Form D)
- Latest fund on file
- IVP XVIII-B
- Filed
- 22 Oct 2026 (new notice)
- Fund size
- $47M (amount sold)
- Fund vehicles filed in the last 12 months
- 7 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For IVP: Venture capital for the Exceptional, the paid file holds: 8 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Warp SciencesScubaSunoCowboy Space CorporationCape
Sources
- www.sec.gov/Archives/edgar/data/2160376/000216037626000001/
- adviserinfo.sec.gov/firm/summary/290647
- www.ivp.com
- www.sec.gov/Archives/edgar/data/2072060/000110465926080704/
- www.ivp.com/team/
- www.ivp.com/faq/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 59 lists
Series B developer tools investors in the US (21)Growth-stage developer tools investors in the US (24)Series B developer tools investors (27)Series B investors in Silicon Valley (29)Developer tools investors in Silicon Valley (36)Series B medtech investors in the US (36)Growth-stage developer tools investors (39)Medtech investors in Silicon Valley (40)Growth-stage investors in Silicon Valley (41)Series B medtech investors (57)Series B investors in California (60)International investors with a UK office (67)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Growth-stage investors in the San Francisco Bay Area (71)Medtech investors in the San Francisco Bay Area (76)Developer tools investors in California (86)Growth-stage investors in California (89)Healthtech investors in Silicon Valley (91)Medtech investors in California (92)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Growth-stage healthtech investors in the US (121)Series B AI investors in the US (126)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series B investors in the US (165)SaaS investors in Silicon Valley (169)AI investors in Silicon Valley (172)Developer tools venture capital firms in the US (177)Healthtech investors in the San Francisco Bay Area (182)Series B SaaS investors (196)Series B AI investors (204)Developer tools investors (216)Healthtech investors in California (240)Growth-stage investors in the US (288)Growth-stage AI investors (295)Growth-stage healthtech investors (316)Series B investors (339)Venture capital firms in Silicon Valley (341)Growth-stage SaaS investors (344)SaaS investors in the San Francisco Bay Area (347)Medtech venture capital firms in the US (350)AI investors in the San Francisco Bay Area (364)SaaS investors in California (433)Medtech investors (457)AI investors in California (464)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Venture capital firms in the San Francisco Bay Area (768)Venture capital firms in California (1,038)SaaS venture capital firms in the US (1,049)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Venture capital firms in the US (2,975)